Hi L vus!

Are you asking if the continues enrollment slows qpcr testing for p21? Or are you asking if it slows down the whole trial process? Or did I miss your meaning totally?

If p21 is subject - the draw for that at 24hrs post initial kevetrin administration so company can release data on number of samples collected so far if they choose to.

If time of whole trial is subject of your question: I always double ceo projections of time to trial completion - and usually my estimate is closer to reality than theirs.